The Food and Drug Administration (FDA) has approved updated labeling for Unloxcyt™ (cosibelimab-ipdl) for the treatment of adults with metastatic ...

The FDA is expected to decide on treatments for breast cancer, EBV+ post-transplant lymphoproliferative disease, focal segmental glomerulosclerosis, presbyopia, and severe allergic reactions.

HealthDay News — Millions of people rely on continuous glucose monitors to help manage diabetes. But a new alert from the Food and Drug Administration (FDA) warns that some sensors from Abbott may ...

Avance is a nerve allograft derived from the nerve tissue of cadavers. It is used to restore peripheral nerve function following injury by bridging the gaps in damaged nerves. To reduce the risk of ...

Following the expanded approval, the accelerated approval for the later-line CLL/SLL was converted to a traditional approval.

Higher risk for overdose seen with lower adherence for 12 months, discontinuation in three to nine months, discontinuation in less than three months ...

HealthDay News — For the first time in more than 3 decades, the US did not take part in World AIDS Day on December 1, a major change from past years when the day was used to raise awareness about ...